Stock Events

Stock Events

Champions Oncology 

€4.9
6
+€0.08+1.66% Today

Statistics

Day High
5
Day Low
4.98
52W High
8.5
52W Low
4.7
Volume
-
Avg. Volume
-
Mkt Cap
68.04M
P/E Ratio
31.67
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12MarExpected
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q2 2025
Q3 2025
Q4 2025
-0.2
-0.01
0.17
0.36
Expected EPS
0.09
Actual EPS
-0.02

Financials

8.49%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
103.01MRevenue
8.75MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2I3.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is involved in oncology drug development and personalized medicine, competing in the cancer treatment market.
Merck
MRK
Mkt Cap214.76B
Merck is a leading pharmaceutical company with a strong focus on cancer therapies, directly competing in the oncology sector.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that has a significant presence in the development of cancer treatments.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG specializes in biotech treatments for cancer, making it a direct competitor in oncology research.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a pharmaceutical company with a strong emphasis on cancer drugs, competing in the oncology market.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company is engaged in the development of oncology products, competing in the cancer treatment space.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a biopharmaceutical company focusing on the development of cancer treatments, making it a competitor.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotech firm with a focus on cancer therapeutics, competing in the oncology market.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is involved in the research and development of oncology drugs, making it a competitor in the cancer treatment market.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals is engaged in the development of cancer treatments, competing in the oncology sector.

About

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Show more...
CEO
Dr. Ronnie Morris M.D.
Employees
213
Country
US
ISIN
US15870P3073
WKN
000A14X6S

Listings

F
DE
2I3.F
XNAS
US
CSBR
BOATS
BOATS
CSBR.BOATS

0 Comments

Share your thoughts

FAQ

What is Champions Oncology stock price today?▼
The current price of 2I3.F is €4.9 EUR — it has increased by +1.66% in the past 24 hours. Watch Champions Oncology stock price performance more closely on the chart.
What is Champions Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Champions Oncology stocks are traded under the ticker 2I3.F.
Is Champions Oncology stock price growing?▼
2I3.F stock has fallen by -0.41% compared to the previous week, the month change is a +0.82% rise, over the last year Champions Oncology has showed a -35.95% decrease.
What is Champions Oncology market cap?▼
Today Champions Oncology has the market capitalization of 68.04M
When is the next Champions Oncology earnings date?▼
Champions Oncology is going to release the next earnings report on July 16, 2026.
What were Champions Oncology earnings last quarter?▼
2I3.F earnings for the last quarter are -0.02 EUR per share, whereas the estimation was 0.08 EUR resulting in a -122.22% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Champions Oncology revenue for the last year?▼
Champions Oncology revenue for the last year amounts to 103.01M EUR.
What is Champions Oncology net income for the last year?▼
2I3.F net income for the last year is 8.75M EUR.
How many employees does Champions Oncology have?▼
As of April 02, 2026, the company has 213 employees.
In which sector is Champions Oncology located?▼
Champions Oncology operates in the Health Care sector.
When did Champions Oncology complete a stock split?▼
Champions Oncology has not had any recent stock splits.
Where is Champions Oncology headquartered?▼
Champions Oncology is headquartered in Hackensack, US.